All of the following statements about nateglinide are true except
Sulfonylureas, nateglinide and repaglinide act by inhibiting ATP sensitive K channels and thus resulting in release of insulin Like insulin All of these drugs can cause hypoglycemia However nateglinide therapy produce fewer episodes of hypoglycemia as compared to other oral insulin secretagogue Nateglinide bad repaglinide are sho acting and thus can reduce post prandial hyperglycemia
Decreses post prandial hyperglycemia
Hypoglycemia is less common than with Sulfonylureas
It decreases insulin resistance
It acts by releasing insulin
Endocrinology